Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury.

Nakayama Y, Ueda S, Yamagishi S, Obara N, Taguchi K, Ando R, Kaida Y, Iwatani R, Kaifu K, Yokoro M, Toyonaga M, Kusumoto T, Fukami K, Okuda S.

Kidney Int. 2014 Mar;85(3):570-8. doi: 10.1038/ki.2013.398. Epub 2013 Oct 9.

2.

Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.

Betz B, Möller-Ehrlich K, Kress T, Kniepert J, Schwedhelm E, Böger RH, Wanner C, Sauvant C, Schneider R.

Transl Res. 2013 Aug;162(2):67-76. doi: 10.1016/j.trsl.2013.04.005. Epub 2013 May 22.

PMID:
23707198
3.

Changes in ADMA/DDAH pathway after hepatic ischemia/reperfusion injury in rats: the role of bile.

Ferrigno A, Rizzo V, Bianchi A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M.

Biomed Res Int. 2014;2014:627434. doi: 10.1155/2014/627434. Epub 2014 Aug 27.

4.

Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.

Stühlinger MC, Conci E, Haubner BJ, Stocker EM, Schwaighofer J, Cooke JP, Tsao PS, Pachinger O, Metzler B.

Cardiovasc Res. 2007 Jul 15;75(2):417-25. Epub 2007 May 5.

PMID:
17559823
5.

Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.

Trocha M, Merwid-Ląd A, Chlebda-Sieragowska E, Szuba A, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Szeląg A, Sozański T.

Exp Gerontol. 2014 Feb;50:45-51. doi: 10.1016/j.exger.2013.11.004. Epub 2013 Nov 20.

PMID:
24269305
6.

Effect of ischemia-reperfusion on renal expression and activity of N(G)-N(G)-dimethylarginine dimethylaminohydrolases.

Li Volti G, Sorrenti V, Acquaviva R, Murabito P, Gullo A, Barcellona ML, Galvano F, Rodella L, Rezzani R, Vanella L, Tringali G, Caruso M, Gazzolo D, Di Giacomo C.

Anesthesiology. 2008 Dec;109(6):1054-62. doi: 10.1097/ALN.0b013e31818d8a77.

PMID:
19034102
7.

Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.

Trocha M, Merwid-Ląd A, Sozański T, Ewa Chlebda-Sieragowska E, Szuba A, Dzięgiel P, Pieśniewska M, Fereniec-Gołębiewska L, Kwiatkowska J, Gomułkiewicz A, Cwynar-Zając Ł, Brykner R, Szeląg A.

Pharmacol Rep. 2013;65(1):122-33.

8.

Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.

Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.

J Am Soc Nephrol. 2006 Aug;17(8):2176-83. Epub 2006 Jun 28.

9.

Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.

Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW.

Cardiovasc Drugs Ther. 2006 Aug;20(4):281-94.

PMID:
16897158
10.

Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.

Sharma S, Smith A, Kumar S, Aggarwal S, Rehmani I, Snead C, Harmon C, Fineman J, Fulton D, Catravas JD, Black SM.

Vascul Pharmacol. 2010 May-Jun;52(5-6):182-90. doi: 10.1016/j.vph.2009.11.010. Epub 2009 Dec 3.

11.

Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Aldámiz-Echevarría L, Andrade F.

Int J Mol Sci. 2012;13(9):11288-311. doi: 10.3390/ijms130911288. Epub 2012 Sep 10. Review.

12.

Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease.

Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T, Okuda S.

J Am Soc Nephrol. 2007 May;18(5):1525-33. Epub 2007 Apr 4.

13.

Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.

Dayoub H, Rodionov RN, Lynch C, Cooke JP, Arning E, Bottiglieri T, Lentz SR, Faraci FM.

Stroke. 2008 Jan;39(1):180-4. Epub 2007 Dec 6. Erratum in: Stroke. 2008 Aug;39(8): e142.

14.

Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.

Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.

Nephrol Dial Transplant. 2009 Apr;24(4):1162-9. doi: 10.1093/ndt/gfn630. Epub 2008 Nov 17.

PMID:
19015171
15.

Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.

Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T.

Metabolism. 2012 Apr;61(4):482-90. doi: 10.1016/j.metabol.2011.08.007. Epub 2011 Oct 13.

PMID:
22000584
16.

Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.

Tanaka M, Sydow K, Gunawan F, Jacobi J, Tsao PS, Robbins RC, Cooke JP.

Circulation. 2005 Sep 13;112(11):1549-56. Epub 2005 Sep 6.

17.

Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.

Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH.

Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):152-6. doi: 10.1016/j.ejogrb.2011.12.032. Epub 2012 Jan 28.

PMID:
22285683
18.

Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.

Kocak C, Kocak FE, Akcilar R, Bayat Z, Aras B, Metineren MH, Yucel M, Simsek H.

Clin Exp Pharmacol Physiol. 2016 Feb;43(2):230-41. doi: 10.1111/1440-1681.12511.

PMID:
26515498
19.

[The role of asymmetric dimethylarginine in the regulation of nitric oxide level in rats with acute renal injury].

Sukhovershin RA, Gilinskiĭ MA.

Ross Fiziol Zh Im I M Sechenova. 2012 Apr;98(4):497-505. Russian.

PMID:
22834339
20.

Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.

Desai A, Zhao Y, Warren JS.

Nephrol Dial Transplant. 2008 May;23(5):1513-20. doi: 10.1093/ndt/gfm869. Epub 2008 Jan 19.

PMID:
18204093

Supplemental Content

Support Center